Comparative evaluation of the HER-2 gene status in breast carcinoma with immunohistochemistry, chromogenic in situ hybridization and real-time quantitative PCR

被引：0
|
作者：
Rousseau, A.
Marie, B.
Martinet, N.
Ventard, E.
Weinbreck, N.
Bressenot, A.
Montagne, K.
Leroux, A.
Vignaud, J. M.
机构：
[1] Nancy Univ Hosp, Nancy, France
[2] INSERM, Nancy, France
[3] CLCC Alexis Vautrin, Vandoeuvre Les Nancy, France
来源：
MODERN PATHOLOGY | 2008年 / 21卷
关键词：
D O I：
暂无
中图分类号：
R36 [病理学];
学科分类号：
100104 ;
摘要：
229
引用
收藏
页码：52A / 52A
页数：1
相关论文
共 50 条
  • [31] Chromogenic in situ hybridization for Her-2/neu-oncogene in breast cancer: comparison of a new dual-colour chromogenic in situ hybridization with immunohistochemistry and fluorescence in situ hybridization
    Mayr, Doris
    Heim, Sibylle
    Weyrauch, Kerstin
    Zeindl-Eberhart, Evelyn
    Kunz, Anne
    Engel, Jutta
    Kirchner, Thomas
    HISTOPATHOLOGY, 2009, 55 (06) : 716 - 723
  • [32] Prognostic relevance of HER-2/neu status determined by Immunohistochemistry, Chromogenic in Situ Hybridization (CISH) and FISH in Lymph-node negative breast carcinoma
    Peiro, Gloria
    Adrover, Encarna
    Alenda, Cristina
    Peiro, Francisca
    Aranda, Ignacio
    ANNALS OF ONCOLOGY, 2004, 15 : 62 - 62
  • [33] Reliability of chromogenic in situ hybridization for detecting HER-2 gene status in breast cancer:: comparison with fluorescence in situ hybridization and assessment of interobserver reproducibility
    Gong, Y
    Gilcrease, M
    Sneige, N
    MODERN PATHOLOGY, 2005, 18 (08) : 1015 - 1021
  • [34] Comparative Assessment of Immunohistochemistry (IHC), Fluorescence In Situ Hybridization (FISH), and Silver-Enhanced In Situ Hybridization (SISH) for Evaluation of HER2 Gene Status in Breast Carcinoma
    Ryu, Y.
    Jeong, H.
    Kim, Y.
    Kim, B.
    Kim, H.
    Kim, A.
    MODERN PATHOLOGY, 2010, 23 : 70A - 70A
  • [35] Performance of chromogenic in situ hybridization on testing HER2 status in breast carcinoma
    Bchir, A.
    Abdessayed, N.
    Ben Abdelkhader, A.
    Mokni, M.
    HISTOPATHOLOGY, 2022, 81 : 32 - 32
  • [36] Comparative Assessment of Immunohistochemistry (IHC), Fluorescence In Situ Hybridization (FISH), and Silver-Enhanced In Situ Hybridization (SISH) for Evaluation of HER2 Gene Status in Breast Carcinoma
    Ryu, Y.
    Jeong, H.
    Kim, Y.
    Kim, B.
    Kim, H.
    Kim, A.
    LABORATORY INVESTIGATION, 2010, 90 : 70A - 70A
  • [37] HER2 status in invasive breast cancer: Immunohistochemistry, fluorescence in-situ hybridization and chromogenic in-situ hybridization
    Shirsat, Hemlata S.
    Epari, Sridhar
    Shet, Tanuja
    Bagal, Rajani
    Hawaldar, Rohini
    Desai, Sangeeta B.
    INDIAN JOURNAL OF PATHOLOGY AND MICROBIOLOGY, 2012, 55 (02) : 175 - 179
  • [38] Preoperative assessment of HER-2/neu status in breast carcinoma: The role of quantitative real-time PCR on core-biopsy specimens
    Susini, Tommaso
    Bussani, Cecilia
    Marini, Giulia
    Nori, Jacopo
    Olivieri, Simone
    Molino, Cecilia
    Bianchi, Simonetta
    Vezzosi, Vania
    Paglierani, Milena
    Giachi, Massimo
    Borrani, Elena
    Scarselli, Gianfranco
    GYNECOLOGIC ONCOLOGY, 2010, 116 (02) : 234 - 239
  • [39] Automated Silver-enhanced In Situ Hybridization for Evaluation of HER2 Gene Status in Breast Carcinoma: Comparison with Fluorescence In Situ Hybridization and Immunohistochemistry
    Sung, Woo Jung
    Park, Seok Ju
    Gu, Mi Jin
    Bae, Young Kyung
    KOREAN JOURNAL OF PATHOLOGY, 2010, 44 (01) : 28 - 34
  • [40] Detection of Her-2/neu oncogene in breast carcinoma by chromogenic in situ hybridization in cytologic specimens
    Lin, F
    Shen, T
    Prichard, JW
    DIAGNOSTIC CYTOPATHOLOGY, 2005, 33 (06) : 376 - 380
12345